NASDAQ-100

349.45 0.98%

1M0.00% 1Y -0.00%  

Analysts Review about Vertex Pharmaceuticals Incorporated Common Stock

Market Consensus (13 Analysts)

Strong Buy

Price Target High $388.40

Spread: 12.23%

Price Target Average $373.46

Spread: 7.92%

Price Target Low $331.12

Spread: -4.32%

Can Google Stock Rebound To $150 In 2023?

AI Stock Breaks Out Ahead Of Earnings; Is AI Stock A Buy Now?

Technical Analyses Trend

Periods

Trend

Resistance

Support

Short Term

Bearish

405.43 (16.02%)

395.59 (13.20%)

Mid Term

Bearish

428.23 (22.54%)

395.59 (13.20%)

Long Term

Bearish

438.54 (25.50%)

341.33 (-2.32%)

  • 1W
  • 1M
  • 1Y

Vertex Pharmaceuticals Incorporated Common Stock Articles

The Motley Fool

Prediction: These 6 AI Stocks Will Be Worth a Combined $20 Trillion by 2030

The top six AI stocks are currently worth a combined $9.5 trillion. They could reach $20 trillion or more by 2030 via different paths, with AI serving as a key tailwind.

Sentiment: Positive 2023-05-30

Proactive Investors

Sirius Real Estate completes early refinancing of debt

Sirius Real Estate said it completed the early refinancing of its €58.3mln debt facility with Deutsche Pfandbriefbank seven months before the due date. A statement from the owner and operator of business and industrial parks said the refinancing comprises a seven-year €58.3mln facility with a fixed interest rate of 4.25%.

Sentiment: Positive 2023-05-30

Zacks Investment Research

Loan Growth Supports M&T Bank (MTB) Despite Rising Costs

M&T Bank's (MTB) top line gets support from increasing loan and deposit balances. Continued rising expenses keep the bottom line under pressure, while worsening credit quality is worrisome.

Sentiment: Negative 2023-05-30

S&P Stocks Review about Vertex Pharmaceuticals Incorporated Common Stock

SPS Rank 776th

SPS Rate 3.3

SPS Consensus (08 Analysts) Sell

Target Price 507.25 USD 45.16%

Potentials Excellent

Growth (Revenue) Excellent

Finances Excellent

Profitability Excellent

Earnings Quality Good

P/E Ratio Excellent

Valuation Overvalued

Fair Value 286.23USD -18.09%

Source

Sentiment

2023-05-30 Here's Why Schlumberger (SLB) is a Strong Value Stock

Za

Positive

2023-05-30 Schlumberger Limited: A Bet On Carbon Capture Capabilities

Se

Positive

2023-05-30 P&G stock leads the Dow's losers as debt-ceiling optimism turns investors away from safety of consumer staples

Ma

Negative

2023-05-29 3 Top Growth Stocks to Make You the Millionaire Next Door

In

Positive

2023-05-29 3 Tech Stocks That Will Reign Supreme in the New World

In

Positive

2023-05-29 The 7 Best Dividend Stocks to Buy for Your Grandchildren

In

Positive

2023-05-29 Caterpillar, Target Among 10 Companies To Announce Annual Dividend Increases In June

Se

Positive

2023-05-29 Buy 8 May Buffett Dividend Dogs And Watch 7

Se

Positive

Vertex Pharmaceuticals Incorporated Common Stock Overview 30 Nov 2020

Open 347.53

High 349.64

Low 346.09

1 Day Change (Last) 3.39

1 Day Change Percent (Last) 0.98%

Close 349.45

Previous Close 346.06

Volume 231,605

52 Week High 367.00

52 Week low 271.61

Gross Margin % 87.90%

Net Profit Margin % 37.20%

Total Shares Outstanding 257.55M

Market Capitalization 93.35B

Vertex Pharmaceuticals Incorporated Common Stock Weight (VRTX) 0.04%

Dividends

Dividends Paid (Last Quarter) No Dividends

Dividends Paid (Last Fiscal Year)No Dividends

Dividends Per Share (Last Quarter) No Dividends

Dividends Yield (Last Fiscal Year) No Dividends

Dividends Per Share (Last Fiscal Year) No Dividends

Income Statement

Net Income (Last Fiscal Year) 3.32B

1 year Revenue8.93B

Last Quarter Revenue2.34B

4 months EPS revision 11.96